Clinical Trial Update: Ixabepilone to Treat Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of ixabepilone for cervical cancer has been terminated; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Adenocarcinoma
• Cervical Adenosquamous Carcinoma
• Cervical Carcinoma
• Cervical Carcinoma Non-squamous Type

Drugs mentioned

• Ixabepilone (ixabepilone)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cervical Carcinoma, Cervical Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2014-06-09